Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2017-01-31
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Intra-articular and Peri-articular Platelet-rich Plasma (PRP) Injections ın Chronic Knee Osteoarthritis
NCT07339137
Investigation of the Effects of Physiotherapy in Patients With Platelet Rich Plasma (PRP) Applied Knee Osteoarthritis
NCT04387396
Comparison of Intra-articular Steroid Injection and Radiofrequency Thermocoagulation in Coxarthrosis Patients
NCT05564065
Effects of Platelet-Rich Plasma and Ozone Therapy in Knee Osteoarthritis
NCT06631456
Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis
NCT03886142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each patient received three times intra-articuler injections of PRP under ultrasound guidance, and they were administered once a week.
Baseline: Visual Analog Scale (VAS) including movement, rest and night, the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) and SF-36 assessment
1st month: VAS, WOMAC and SF-36 assessment
3rd month: VAS, WOMAC and SF-36 assessment
6th month: VAS, WOMAC and SF-36 assessment
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRP injection group
Intra-articular PRP injection with ultrasound guidance
Three times PRP injections with an interval of one week
intra-articular PRP injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intra-articular PRP injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Grade 1 and 2 osteoarthritis according to the Kellgren-Lawrence classification
* No pathologies in the laboratory and coagulation parameters
Exclusion Criteria
* Systemic active infection
* Severe cardiovascular disease
* Malignancy
* NSAID usage in the last week
* History of hip joint surgery
* History of traumatic hip injury
* Hgb values \< 11 gr/dl
* Platelets values \< 150.000 / µl
* History of bleeding disorder
50 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sisli Hamidiye Etfal Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Selda Çiftci
Specialist, Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jülide Öncü Alptekin
Role: STUDY_CHAIR
Şişli Hamidiye Etfal Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Şişli Hamidiye Etfal Training and Research Hospital
Istanbul, Şişli, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
191
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.